Table 4.
Long-term clinical results in the success and failure groups.
| Variables | Success (656 pts) | Failure (82 pts) | p-value |
|---|---|---|---|
| Follow-up days | 1531.3 ± 33.5 | 1565.3 ± 97.5 | 0.72 |
| TVR | 94 (14.3) | N/A | N/A |
| Reocclusion | 42 (6) | N/A | N/A |
| Follow-up creatinine (mg/dL) | 1.4 ± 0.1 | 1.9 ± 0.3 | 0.17 |
| Follow-up LVEF(%) | 53.5 ± 12.7 | 49.1 ± 10.3 | 0.11 |
| Radiation dermatitis | 7 (1.1) | 4 (4.9) | 0.007 |
| Subsequent CABG | 14 (2.1) | 7 (8.5) | 0.001 |
| Subsequent hemodialysis | 16 (2.4) | 2 (2.4) | – |
| CHF | 22 (3.4) | 6 (7.3) | 0.07 |
| Stroke | 7 (1.1) | 4 (4.9) | 0.007 |
| All cause death | 64 (9.8) | 19 (23.2) | 0.0003 |
| Evident cardiac death | 23 (3.5) | 13 (15.9) | < 0.0001 |
Values are number, (%); TVR = target vessel revascularization; CABG = coronary artery bypass grafting; HD = hemodialysis; CHF = congestive heart failure; LVEF = left ventricular ejection fraction.